Company Name or Ticker Symbol
Search for other Categories
Alexion Pharmaceuticals, Inc.  (ALXN)
Other Ticker:  
Price: $129.8400 $0.91 0.706%
Day's High: $129.38 Week Perf: 3.72 %
Day's Low: $ 128.51 30 Day Perf: 10.93 %
Volume (M): 108 52 Wk High: $ 140.77
Volume (M$): $ 13,954 52 Wk Avg: $119.66
Open: $128.51 52 Wk Low: $93.67

 Market Capitalization (Millions $) 29,487
 Shares Outstanding (Millions) 227
 Employees 2,273
 Revenues (TTM) (Millions $) 4,131
 Net Income (TTM) (Millions $) 78
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 213

Alexion Pharmaceuticals, Inc.
We are a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Our marketed product Soliris® (eculizumab) is the first and only therapeutic approved for patients with two severe and ultra-rare disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening and ultra-rare genetic blood disorder, and atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. We are also evaluating additional potential indications for Soliris in severe and ultra-rare diseases in which chronic uncontrolled complement activation is the underlying mechanism, and we are progressing in various stages of development with additional biotechnology product candidates as treatments for patients with severe and ultra-rare disorders. We were incorporated in 1992 and began commercial sale of Soliris in 2007.

ALXN is expected to report next financial results on April 22, 2019.

Alexion Pharmaceuticals's Segments
  Company Estimates  
  Revenue Outlook
Alexion Pharmaceuticals announced annual revenue outlook on Oct. 29, 2015

Earnings Outlook
Alexion Pharmaceuticals, Inc. issued annual earnings guidance on Oct. 29, 2015

Geographic Revenue Dispersion
United States 35.31 %
Europe 36.89 %
Asia Pacific 14.24 %
Other 13.56 %

Pilgrims Pride Corp

Pilgrims Pride Corp announced forth quarter operating surplus of $495.686 millions

Pilgrims Pride Corp announced very strong Sales growth of 298.85 % year on year to $10.94 billions in the forth quarter, but posted loss at $-0.01.

Equity Commonwealth

Equity Commonwealth announced forth quarter operating income of $7.583 millions

Equity Commonwealth announced earnings per share of $0.11 and Sales of $46.87 millions in the forth quarter, Company's earnings turn positive per share, versus $-0.19 eps, earned in the same quarter a year ago, although Equity Commonwealth saw it's Sales rise by 52.19 % in the same period.

Cognex Corp

Cognex Corp announced forth quarter operating surplus of $45.247 millions

In the forth quarter Cognex Corp earnings turn positive of $0.26 per share compare to $-0.05 a year ago and profit plummeted by -42.52 % from $0.45 per share from the previous quarter.

Sales declined by -5.86 % to $193.29 millions from $205.32 millions in the same quarter a year ago and sequentially Sales fell by -16.77 % from $232.22 millions.

Escalon Medical Corp.

Escalon Medical Corp announced second quarter operating shortfall of $-0.226547 millions

Weak demand caused increase in losses for the second quarter, company's loss per share grew at $-0.03 from $0.09 where Sales fell by -28.5 % to $2.42 millions from $3.38 millions a year ago.

Sunpower Corp

Company's earnings faded on asset impairments of $368.06 million in the forth quarter

Company's earnings faded on asset impairments of $368.06 million in the forth quarter

Customers Net Income fell by ALXN's customers Net margin fell to 0 %
-22.74 % 3.58 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers

You need to upgrade your Flash Player

Major Competitors Stock performance

5 Days Decrease / Increase
AMGN   -0.8%    
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SANM's Profile

Stock Price

SANM's Financials

Business Description


Charts & Quotes

SANM's News


SANM's Competitors

Customers & Markets

Economic Indicators

SANM's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071